Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity?

Omachi TA, Gregorich SE, Eisner MD, Penaloza RA, Tolstykh IV, Yelin EH, Iribarren C, Dudley RA, Blanc PD.

Med Care. 2013 Aug;51(8):740-7. doi: 10.1097/MLR.0b013e318298082f.


Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

J Manag Care Pharm. 2008 Mar;14(2):176-85.


The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ.

N Engl J Med. 2004 Mar 4;350(10):1005-12.


A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations.

Motegi T, Jones RC, Ishii T, Hattori K, Kusunoki Y, Furutate R, Yamada K, Gemma A, Kida K.

Int J Chron Obstruct Pulmon Dis. 2013;8:259-71. doi: 10.2147/COPD.S42769. Epub 2013 May 31.


Adrenomedullin refines mortality prediction by the BODE index in COPD: the "BODE-A" index.

Stolz D, Kostikas K, Blasi F, Boersma W, Milenkovic B, Lacoma A, Louis R, Aerts JG, Welte T, Torres A, Rohde GG, Boeck L, Rakic J, Scherr A, Hertel S, Giersdorf S, Tamm M.

Eur Respir J. 2014 Feb;43(2):397-408. doi: 10.1183/09031936.00058713. Epub 2013 Jun 21. Erratum in: Eur Respir J. 2014 Dec;44(6):1718.


Experience of fatigue, and its relationship to physical capacity and disease severity in men and women with COPD.

Tödt K, Skargren E, Kentson M, Theander K, Jakobsson P, Unosson M.

Int J Chron Obstruct Pulmon Dis. 2014;9:17-25. doi: 10.2147/COPD.S52506. Epub 2013 Dec 16.


The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.

Lin YX, Xu WN, Liang LR, Pang BS, Nie XH, Zhang J, Wang H, Liu YX, Wang DQ, Xu ZY, Wang HW, Zhang HS, He ZY, Yang T, Wang C.

Chin Med J (Engl). 2009 Dec 20;122(24):2939-44.


[Relationship between disease severity, smoking index age and direct costs of hospital treatment of COPD exacerbations].

Targowski T, Jahnz-Rózyk K, From S, Płusa T.

Pneumonol Alergol Pol. 2005;73(1):32-5. Polish.


Validation of the i-BODE index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation.

Moberg M, Vestbo J, Martinez G, Williams JE, Ladelund S, Lange P, Ringbaek T.

COPD. 2014 Aug;11(4):381-7. doi: 10.3109/15412555.2013.836171. Epub 2013 Oct 10.


[Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test in chronic obstructive pulmonary disease with severe airflow limitation].

Bermudo G, Pomares X, Montón C, Baré M, Monsó E.

Med Clin (Barc). 2014 Oct 21;143(8):349-51. doi: 10.1016/j.medcli.2013.08.006. Epub 2013 Nov 7. Spanish.


Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA.

Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi: 10.2147/COPD.S36997. Epub 2012 Nov 1.


Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting.

Miravitlles M, Sicras A, Crespo C, Cuesta M, Brosa M, Galera J, Lahoz R, Lleonart M, Riera MI.

Ther Adv Respir Dis. 2013 Jun;7(3):139-50. doi: 10.1177/1753465813484080. Epub 2013 May 7.


BODE-index, modified BODE-index and ADO-score in chronic obstructive pulmonary disease: relationship with COPD phenotypes and CT lung density changes.

Camiciottoli G, Bigazzi F, Bartolucci M, Cestelli L, Paoletti M, Diciotti S, Cavigli E, Magni C, Buonasera L, Mascalchi M, Pistolesi M.

COPD. 2012 Jun;9(3):297-304. doi: 10.3109/15412555.2012.661000. Epub 2012 Mar 20.


Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

Puhan MA, Garcia-Aymerich J, Frey M, ter Riet G, Antó JM, Agustí AG, Gómez FP, Rodríguez-Roisín R, Moons KG, Kessels AG, Held U.

Lancet. 2009 Aug 29;374(9691):704-11. doi: 10.1016/S0140-6736(09)61301-5.


Inspiratory capacity, exercise limitation, markers of severity, and prognostic factors in chronic obstructive pulmonary disease.

Freitas CG, Pereira CA, Viegas CA.

J Bras Pneumol. 2007 Jul-Aug;33(4):389-96. English, Portuguese.


Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease.

Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K.

Int J Chron Obstruct Pulmon Dis. 2011;6:521-6. doi: 10.2147/COPD.S24420. Epub 2011 Oct 11.


Sex differences in mortality in patients with COPD.

de Torres JP, Cote CG, López MV, Casanova C, Díaz O, Marin JM, Pinto-Plata V, de Oca MM, Nekach H, Dordelly LJ, Aguirre-Jaime A, Celli BR.

Eur Respir J. 2009 Mar;33(3):528-35. doi: 10.1183/09031936.00096108. Epub 2008 Dec 1.


Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study.

Cardoso F, Tufanin AT, Colucci M, Nascimento O, Jardim JR.

Chest. 2007 Aug;132(2):477-82. Epub 2007 May 15.


BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice?

Esteban C, Quintana JM, Moraza J, Aburto M, Aguirre U, Aguirregomoscorta JI, Aizpiri S, Basualdo LV, Capelastegui A.

BMC Med. 2010 May 24;8:28. doi: 10.1186/1741-7015-8-28.


Association between periodontitis and chronic obstructive pulmonary disease in a Chinese population.

Si Y, Fan H, Song Y, Zhou X, Zhang J, Wang Z.

J Periodontol. 2012 Oct;83(10):1288-96. Epub 2012 Jan 16.


Supplemental Content

Support Center